世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の画像誘導インターベンションシステム市場予測 2019-2027年

GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET FORECAST 2019-2027

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2018年11月US$2,500
シングルユーザライセンス(印刷不可PDF)
120

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは世界の画像誘導インターベンションシステム市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The leading industry of the health care sector is that of the medical devices which are highly dynamic mainly because of product launches in the active fields of imaging, diagnostics and therapeutics. Pre-surgical and surgical interventions are heavily dependent on the imaging system for their maximum efficiency and patient’s accurate diagnosis. The image-guided intervention market is on the verge of positive growth owing to the need for a high precision system to guide in the most critical surgical procedure. The global image-guided intervention market is progressing at a CAGR of 5.08% during the forecast years.

MARKET INSIGHTS

Cost-containment measures to reduce the healthcare burden, especially in developed economies are adopted by the respective governments, healthcare providers, insurance payers and life sciences companies to aid maximum value for money spent on healthcare and achieve better health outcomes. This factor is mainly driving the industry globally. Though this technology is vital to clinical diagnosis and treatment, the risk of radiation exposure in interventional cardiology procedures such as coronary angiography and left ventriculography cannot be overlooked.

REGIONAL INSIGHTS
The global market for image-guided intervention is geographically segmented into different regions like North America, Europe, Asia Pacific and the Rest of the World to gain further market insights for analysis. The region of North America is found to hold the largest market share for image-guided intervention globally. Rising number of healthcare services coupled with rising healthcare expenditure and customer affordability is expected to drive this humongous market in the North American region.
Different government bodies in different regions regulate the approval and sales of medical devices that can restrict market growth.

COMPETITIVE INSIGHTS

The global market leaders are leveraging on their strong business segment and are launching various new modalities to gain an edge over the other. Some of these market players are Arthrex, B. Braun Melsungen AG, Boston Scientific Corporation, Canon Inc., C.R. Bard, Inc., Dentsply Sirona Inc., Elekta AB, Fujifilm Holdings Corporation and GE Healthcare.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. SINGLE PLANE PRODUCTS HOLD THE LARGEST MARKET SHARE
3.2.2. IVUS, FFR, IFR ARE ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD IN TERMS OF MODALITY
3.2.3. CARDIOLOGY IS THE WIDELY USED APPLICATION
3.2.4. SPECIALTY CLINICS ARE THE FASTEST GROWING END USER
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. SHIFTING FOCUS FROM VOLUME?BASED TO VALUE?BASED SYSTEM
4.2.2. DEVELOPING EMERGING MARKETS
4.2.3. GROWING DEMAND FOR IMAGING TECHNOLOGY
4.2.4. INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
4.2.5. RISING DEMAND FOR INTERVENTIONAL IMAGING IN FRACTURES AND TRAUMATIC INJURIES
4.2.6. FAVORABLE REIMBURSEMENT SCENARIOS
4.3. MARKET RESTRAINTS
4.3.1. HIGH COST OF HYBRID OPERATING ROOM EQUIPMENT
4.3.2. LIMITATIONS IN INTERVENTIONAL IMAGE-GUIDED SYSTEMS
4.4. MARKET OPPORTUNITIES
4.4.1. ACCEPTANCE OF HYBRID IMAGING AMONG END USERS
4.4.2. OUTSOURCING OF SOLUTION FOR SURGICAL THEATERS PROVIDING QUALITY IMAGING TO THE SURGEONS
4.5. MARKET CHALLENGES
4.5.1. REAL-TIME IMAGING CHALLENGES
5. MARKET BY PRODUCTS
5.1. SINGLE PLANE
5.2. BI-PLANE SYSTEMS
6. MARKET BY TYPES
6.1. CT IMAGE-GUIDED SYSTEMS
6.2. X-RAY FLUOROSCOPY IMAGE-GUIDED SYSTEMS
6.3. MRI IMAGE-GUIDED SYSTEMS
6.4. PET IMAGE-GUIDED SYSTEMS
6.5. ULTRASOUND IMAGE-GUIDED SYSTEMS
6.6. ENDOSCOPE IMAGE-GUIDED SYSTEMS
6.7. SPECT IMAGE-GUIDED SYSTEMS
7. MARKET BY MODALITY
7.1. VASCULAR INTERVENTIONAL SYSTEMS
7.2. IVUS, FFR, IFR
7.3. INTRAOPERATIVE ULTRASOUND SCANNER
7.4. FLUOROSCOPY
7.5. INTRAOPERATIVE CT SCANNER
7.6. ENDOSCOPES SYSTEMS
7.7. INTRAOPERATIVE MRI SCANNER
7.8. OTHER MODALITY
8. MARKET BY APPLICATION
8.1. CARDIOLOGY
8.2. NEUROLOGY
8.3. ONCOLOGY
8.4. GASTROENTEROLOGY
8.5. ORTHOPEDICS
8.6. ENT SURGERY
8.7. OTHER APPLICATIONS
9. MARKET BY END USER
9.1. HOSPITALS
9.2. AMBULATORY SURGICAL CENTERS
9.3. SPECIALTY CLINICS
10. KEY ANALYTICS
10.1. PORTERS FIVE FORCES ANALYSIS
10.1.1. THREAT OF NEW ENTRANTS
10.1.2. THREAT OF SUBSTITUTE
10.1.3. BARGAINING POWER OF SUPPLIERS
10.1.4. BARGAINING POWER OF BUYERS
10.1.5. THREAT OF COMPETITIVE RIVALRY
10.2. SUPPLY CHAIN ANALYSIS
10.3. REGULATORY FRAMEWORK
10.3.1. NORTH AMERICA MEDICAL DEVICE REGULATIONS
10.3.2. EUROPE MEDICAL DEVICE REGULATIONS
10.3.3. ASIA-PACIFIC MEDICAL DEVICE REGULATIONS
10.3.4. LATIN AMERICA MEDICAL DEVICE REGULATIONS
10.3.5. MIDDLE EAST AND AFRICA MEDICAL DEVICE REGULATIONS
10.4. REGULATORY BODIES
10.5. OPPORTUNITY MATRIX
11. GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1. THE UNITED STATES
11.1.2. CANADA
11.2. EUROPE
11.2.1. GERMANY
11.2.2. THE UNITED KINGDOM
11.2.3. FRANCE
11.2.4. SPAIN
11.2.5. ITALY
11.2.6. REST OF EUROPE
11.3. ASIA PACIFIC
11.3.1. CHINA
11.3.2. INDIA
11.3.3. JAPAN
11.3.4. AUSTRALIA
11.3.5. SOUTH KOREA
11.3.6. REST OF APAC
11.4. REST OF WORLD
11.4.1. LATIN AMERICA
11.4.2. MIDDLE EAST AND AFRICA
12. COMPETITIVE LANDSCAPE
12.1. MARKET SHARE ANALYSIS
12.2. COMPANY PROFILE
12.2.1. ARTHREX
12.2.1.1. COMPANY OVERVIEW
12.2.1.2. PRODUCT PORTFOLIO
12.2.1.3. SCOT ANALYSIS
12.2.1.4. STRATEGIC MOVES
12.2.2. B.BRAUN MELSUNGEN AG
12.2.2.1. OVERVIEW
12.2.2.2. PRODUCT PORTFOLIO
12.2.2.3. SCOT ANALYSIS
12.2.2.4. STRATEGIC ANALYSIS
12.2.3. BOSTON SCIENTIFIC CORPORATION
12.2.3.1. COMPANY OVERVIEW
12.2.3.2. PRODUCT PORTFOLIO
12.2.3.3. SCOT ANALYSIS
12.2.3.4. STRATEGIC INITIATIVES
12.2.4. CANON INC.
12.2.4.1. COMPANY OVERVIEW
12.2.4.2. PRODUCT PORTFOLIO
12.2.4.3. SCOT ANALYSIS
12.2.4.4. STRATEGIC INITIATIVES
12.2.5. C. R. BARD, INC.
12.2.5.1. COMPANY OVERVIEW
12.2.5.2. PRODUCT PORTFOLIO
12.2.5.3. SCOT ANALYSIS
12.2.5.4. STRATEGIC INITIATIVES
12.2.6. DENTSPLY SIRONA INC.
12.2.6.1. COMPANY OVERVIEW
12.2.6.2. SCOT ANALYSIS
12.2.6.3. PRODUCT PORTFOLIO
12.2.6.4. STRATEGIC INITIATIVES
12.2.7. ELEKTA AB
12.2.7.1. COMPANY OVERVIEW
12.2.7.2. PRODUCT PORTFOLIO
12.2.7.3. SCOT ANALYSIS
12.2.7.4. STRATEGIC INITIATIVES
12.2.8. FUJIFILM HOLDINGS CORPORATION
12.2.8.1. COMPANY OVERVIEW
12.2.8.2. PRODUCT PORTFOLIO
12.2.8.3. SCOT ANALYSIS
12.2.8.4. STRATEGIC INITIATIVES
12.2.9. GE HEALTHCARE
12.2.9.1. COMPANY OVERVIEW
12.2.9.2. PRODUCT PORTFOLIO
12.2.9.3. SCOT ANALYSIS
12.2.9.4. STRATEGIC INITIATIVES
12.2.10. HITACHI MEDICAL CORPORATION
12.2.10.1. COMPANY OVERVIEW
12.2.10.2. PRODUCT PORTFOLIO
12.2.10.3. SCOT ANALYSIS
12.2.10.4. STRATEGIC INITIATIVES
12.2.11. HOLOGIC, INC.
12.2.11.1. COMPANY OVERVIEW
12.2.11.2. PRODUCT PORTFOLIO
12.2.11.3. SCOT ANALYSIS
12.2.11.4. STRATEGIC INITIATIVES
12.2.12. KARL STORZ GMBH & CO. KG
12.2.12.1. COMPANY OVERVIEW
12.2.12.2. PRODUCT PORTFOLIO
12.2.12.3. SCOT ANALYSIS
12.2.12.4. STRATEGIC INITIATIVES
12.2.13. KONINKLIJKE PHILIPS N.V.
12.2.13.1. COMPANY OVERVIEW
12.2.13.2. PRODUCT PORTFOLIO
12.2.13.3. SCOT ANALYSIS
12.2.13.4. STRATEGIC INITIATIVES
12.2.14. MEDTRONIC PLC
12.2.14.1. COMPANY OVERVIEW
12.2.14.2. PRODUCT PORTFOLIO
12.2.14.3. SCOT ANALYSIS
12.2.14.4. STRATEGIC INITIATIVES
12.2.15. OLYMPUS CORPORATION
12.2.15.1. COMPANY OVERVIEW
12.2.15.2. PRODUCT PORTFOLIO
12.2.15.3. SCOT ANALYSIS
12.2.15.4. STRATEGIC INITIATIVES
12.2.16. SIEMENS AG
12.2.16.1. COMPANY OVERVIEW
12.2.16.2. PRODUCT PORTFOLIO
12.2.16.3. SCOT ANALYSIS
12.2.16.4. STRATEGIC INITIATIVES
12.2.17. STRYKER CORPORATION
12.2.17.1. COMPANY OVERVIEW
12.2.17.2. PRODUCT PORTFOLIO
12.2.17.3. SCOT ANALYSIS
12.2.17.4. STRATEGIC INITIATIVES
12.2.18. TERUMO CORPORATION
12.2.18.1. COMPANY OVERVIEW
12.2.18.2. PRODUCT PORTFOLIO
12.2.18.3. SCOT ANALYSIS
12.2.18.4. STRATEGIC INITIATIVE


LIST OF TABLES
TABLE 1 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)
TABLE 2 CORONARY AND PROCEDURE REIMBURSEMENT BY MEDICARE IN ASCS
TABLE 3 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 5 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY MODALITY 2019-2027 ($ MILLION)
TABLE 6 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 7 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 8 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 10 EUROPE INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 12 REST OF WORLD INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES
FIGURE 1 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 2 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY TECHNOLOGY 2017 & 2027 (%)
FIGURE 3 ADVANTAGES AND DISADVANTAGES OF SINGLE PLANE
FIGURE 4 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY SINGLE PLANE 2019-2027 ($ MILLION)
FIGURE 5 ADVANTAGES AND DISADVANTAGES OF SINGLE PLANE
FIGURE 6 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY BI-PLANE SYSTEMS 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY TYPES 2017 & 2027 (%)
FIGURE 8 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY CT IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY X-RAY FLUOROSCOPY IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY MRI IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 11 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY PET IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ULTRASOUND IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ENDOSCOPE IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 14 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY SPECT IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 15 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY MODALITY 2017 & 2027 (%)
FIGURE 16 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY VASCULAR INTERVENTIONAL SYSTEMS 2019-2027 ($ MILLION)
FIGURE 17 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY IVUS, FFR, IFR 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY INTRAOPERATIVE ULTRASOUND SCANNER 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY FLUOROSCOPY 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY INTRAOPERATIVE CT SCANNER 2019-2027 ($ MILLION)
FIGURE 21 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ENDOSCOPES SYSTEMS 2019-2027 ($ MILLION)
FIGURE 22 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY INTRAOPERATIVE MRI SCANNER 2019-2027 ($ MILLION)
FIGURE 23 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY OTHER MODALITY 2019-2027 ($ MILLION)
FIGURE 24 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY APPLICATION 2017 & 2027 (%)
FIGURE 25 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY CARDIOLOGY 2019-2027 ($ MILLION)
FIGURE 26 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY NEUROLOGY 2019-2027 ($ MILLION)
FIGURE 27 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
FIGURE 28 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY GASTROENTEROLOGY 2019-2027 ($ MILLION)
FIGURE 29 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ORTHOPEDICS 2019-2027 ($ MILLION)
FIGURE 30 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ENT SURGERY 2019-2027 ($ MILLION)
FIGURE 31 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 32 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY APPLICATION 2017 & 2027 (%)
FIGURE 33 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 34 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
FIGURE 35 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY SPECIALTY CLINICS 2019-2027 ($ MILLION)
FIGURE 36 PORTER’S FIVE FORCE MODEL
FIGURE 37 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 38 THE UNITED STATES INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 39 CANADA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 40 GERMANY INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 41 THE UNITED KINGDOM INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 42 FRANCE INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 43 SPAIN INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 44 ITALY INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 45 REST OF EUROPE INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 46 CHINA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 47 INDIA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 48 JAPAN INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 49 AUSTRALIA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 50 SOUTH KOREA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 51 REST OF APAC INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 52 LATIN AMERICA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 53 MIDDLE EAST AND AFRICA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 54 INTERVENTIONAL IMAGE GUIDED SYSTEM COMPANY MARKET SHARE 2017 (%)

List of Tables

LIST OF TABLES
TABLE 1 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)
TABLE 2 CORONARY AND PROCEDURE REIMBURSEMENT BY MEDICARE IN ASCS
TABLE 3 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 5 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY MODALITY 2019-2027 ($ MILLION)
TABLE 6 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 7 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 8 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 10 EUROPE INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 12 REST OF WORLD INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

LIST OF FIGURES
FIGURE 1 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 2 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY TECHNOLOGY 2017 & 2027 (%)
FIGURE 3 ADVANTAGES AND DISADVANTAGES OF SINGLE PLANE
FIGURE 4 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY SINGLE PLANE 2019-2027 ($ MILLION)
FIGURE 5 ADVANTAGES AND DISADVANTAGES OF SINGLE PLANE
FIGURE 6 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY BI-PLANE SYSTEMS 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY TYPES 2017 & 2027 (%)
FIGURE 8 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY CT IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY X-RAY FLUOROSCOPY IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY MRI IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 11 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY PET IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ULTRASOUND IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ENDOSCOPE IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 14 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY SPECT IMAGE-GUIDED SYSTEMS 2019-2027 ($ MILLION)
FIGURE 15 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY MODALITY 2017 & 2027 (%)
FIGURE 16 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY VASCULAR INTERVENTIONAL SYSTEMS 2019-2027 ($ MILLION)
FIGURE 17 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY IVUS, FFR, IFR 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY INTRAOPERATIVE ULTRASOUND SCANNER 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY FLUOROSCOPY 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY INTRAOPERATIVE CT SCANNER 2019-2027 ($ MILLION)
FIGURE 21 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ENDOSCOPES SYSTEMS 2019-2027 ($ MILLION)
FIGURE 22 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY INTRAOPERATIVE MRI SCANNER 2019-2027 ($ MILLION)
FIGURE 23 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY OTHER MODALITY 2019-2027 ($ MILLION)
FIGURE 24 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY APPLICATION 2017 & 2027 (%)
FIGURE 25 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY CARDIOLOGY 2019-2027 ($ MILLION)
FIGURE 26 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY NEUROLOGY 2019-2027 ($ MILLION)
FIGURE 27 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
FIGURE 28 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY GASTROENTEROLOGY 2019-2027 ($ MILLION)
FIGURE 29 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ORTHOPEDICS 2019-2027 ($ MILLION)
FIGURE 30 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY ENT SURGERY 2019-2027 ($ MILLION)
FIGURE 31 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 32 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET SHARE BY APPLICATION 2017 & 2027 (%)
FIGURE 33 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 34 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
FIGURE 35 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET BY SPECIALTY CLINICS 2019-2027 ($ MILLION)
FIGURE 36 PORTER’S FIVE FORCE MODEL
FIGURE 37 GLOBAL INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 38 THE UNITED STATES INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 39 CANADA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 40 GERMANY INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 41 THE UNITED KINGDOM INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 42 FRANCE INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 43 SPAIN INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 44 ITALY INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 45 REST OF EUROPE INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 46 CHINA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 47 INDIA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 48 JAPAN INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 49 AUSTRALIA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 50 SOUTH KOREA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 51 REST OF APAC INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 52 LATIN AMERICA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 53 MIDDLE EAST AND AFRICA INTERVENTIONAL IMAGE-GUIDED SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 54 INTERVENTIONAL IMAGE GUIDED SYSTEM COMPANY MARKET SHARE 2017 (%)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る